Hamed Manoochehri

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Venues

Cancer gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Mohsen Sheykhhasan, Amirhossein Ahmadieh-Yazdi, Rosario Vicidomini, Naresh Poondla, Hamid Tanzadehpanah, Ashkan Dirbaziyan, Hanie Mahaki, Hamed Manoochehri, Naser Kalhor, Paola Dama
CAR T therapies in multiple myeloma: unleashing the future. Cancer gene therapy 31 (5) (2024)
Mohsen Sheykhhasan, Amirhossein Ahmadieh-Yazdi, Rosario Vicidomini, Naresh Poondla, Hamid Tanzadehpanah, Ashkan Dirbaziyan, Hanie Mahaki, Hamed Manoochehri, Naser Kalhor, Paola Dama
CAR T therapies in multiple myeloma: unleashing the future. Cancer gene therapy (2024)
Mohsen Sheykhhasan, Amirhossein Ahmadieh-Yazdi, Rosario Vicidomini, Naresh Poondla, Hamid Tanzadehpanah, Ashkan Dirbaziyan, Hanie Mahaki, Hamed Manoochehri, Naser Kalhor, Paola Dama
CAR T therapies in multiple myeloma: unleashing the future. Cancer gene therapy 31 (5) (2024)
Mohsen Sheykhhasan, Amirhossein Ahmadieh-Yazdi, Rosario Vicidomini, Naresh Poondla, Hamid Tanzadehpanah, Ashkan Dirbaziyan, Hanie Mahaki, Hamed Manoochehri, Naser Kalhor, Paola Dama
CAR T therapies in multiple myeloma: unleashing the future. Cancer gene therapy 31 (5) (2024)
Mohsen Sheykhhasan, Amirhossein Ahmadieh-Yazdi, Rosario Vicidomini, Naresh Poondla, Hamid Tanzadehpanah, Ashkan Dirbaziyan, Hanie Mahaki, Hamed Manoochehri, Naser Kalhor, Paola Dama
CAR T therapies in multiple myeloma: unleashing the future. Cancer gene therapy (2024)
Mohsen Sheykhhasan, Hamed Manoochehri, Paola Dama
Use of CAR T-cell for acute lymphoblastic leukemia (ALL) treatment: a review study. Cancer gene therapy 29 (8-9) (2022)

Hamed Manoochehri.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hamed Manoochehri